International comparison of spending and utilization at the end of life for hip fracture patients.


Journal

Health services research
ISSN: 1475-6773
Titre abrégé: Health Serv Res
Pays: United States
ID NLM: 0053006

Informations de publication

Date de publication:
12 2021
Historique:
revised: 07 07 2021
received: 15 03 2021
accepted: 08 07 2021
pubmed: 8 9 2021
medline: 15 12 2021
entrez: 7 9 2021
Statut: ppublish

Résumé

To identify and explore differences in spending and utilization of key health services at the end of life among hip fracture patients across seven developed countries. Individual-level claims data from the inpatient and outpatient health care sectors compiled by the International Collaborative on Costs, Outcomes, and Needs in Care (ICCONIC). We retrospectively analyzed utilization and spending from acute hospital care, emergency department, outpatient primary care and specialty physician visits, and outpatient drugs. Patterns of spending and utilization were compared in the last 30, 90, and 180 days across Australia, Canada, England, Germany, New Zealand, Spain, and the United States. We employed linear regression models to measure age- and sex-specific effects within and across countries. In addition, we analyzed hospital-centricity, that is, the days spent in hospital and site of death. We identified patients who sustained a hip fracture in 2016 and died within 12 months from date of admission. Resource use, costs, and the proportion of deaths in hospital showed large variability being high in England and Spain, while low in New Zealand. Days in hospital significantly decreased with increasing age in Canada, Germany, Spain, and the United States. Hospital spending near date of death was significantly lower for women in Canada, Germany, and the United States. The age gradient and the sex effect were less pronounced in utilization and spending of emergency care, outpatient care, and drugs. Across seven countries, we find important variations in end-of-life care for patients who sustained a hip fracture, with some differences explained by sex and age. Our work sheds important insights that may help ongoing health policy discussions on equity, efficiency, and reimbursement in health care systems.

Identifiants

pubmed: 34490633
doi: 10.1111/1475-6773.13734
pmc: PMC8579204
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1370-1382

Informations de copyright

© 2021 The Authors. Health Services Research published by Wiley Periodicals LLC on behalf of Health Research and Educational Trust.

Références

Osteoporos Int. 2016 Feb;27(2):549-58
pubmed: 26286626
JAMA. 2018 Mar 13;319(10):1024-1039
pubmed: 29536101
Age Ageing. 2019 Dec 1;49(1):82-87
pubmed: 31732735
J Palliat Med. 2016 Dec;19(12):1304-1311
pubmed: 27529742
Best Pract Res Clin Rheumatol. 2013 Dec;27(6):711-5
pubmed: 24836330
Health Aff (Millwood). 2016 Jul 1;35(7):1316-23
pubmed: 27307350
Health Serv Res. 2021 Dec;56 Suppl 3:1383-1393
pubmed: 34378190
J Epidemiol Community Health. 2016 May;70(5):430-6
pubmed: 26584859
Osteoporos Int. 2006 Dec;17(12):1726-33
pubmed: 16983459
J Pain Symptom Manage. 2007 May;33(5):542-6
pubmed: 17482044
N Engl J Med. 2016 Sep 8;375(10):909-11
pubmed: 27602661
BMJ. 2015 Oct 07;351:h4855
pubmed: 26446163
J Am Geriatr Soc. 2020 Sep;68(9):1947-1953
pubmed: 32853429
Am J Public Health. 2015 Dec;105(12):2411-5
pubmed: 26469646
N Z Med J. 2004 Jun 18;117(1196):U935
pubmed: 15280939
Sci Rep. 2020 Jun 15;10(1):9607
pubmed: 32541939
J Am Geriatr Soc. 2003 Mar;51(3):364-70
pubmed: 12588580
Health Serv Res. 2010 Apr;45(2):565-76
pubmed: 20148984
Osteoporos Int. 2017 Oct;28(10):2791-2800
pubmed: 28748387
Gac Sanit. 2019 Nov - Dec;33(6):568-574
pubmed: 30390994
BMC Geriatr. 2002 Feb 27;2:1
pubmed: 11897015
BMC Palliat Care. 2013 Feb 15;12:7
pubmed: 23414145
BMC Health Serv Res. 2013 Jul 17;13:275
pubmed: 23866928
Science. 2018 Jun 29;360(6396):1462-1465
pubmed: 29954980
Palliat Med. 2014 Dec;28(10):1167-96
pubmed: 24866758
Health Econ. 2012 Aug;21 Suppl 2:1-5
pubmed: 22815107
BMJ Open. 2018 Sep 8;8(9):e023113
pubmed: 30196269
Health Aff (Millwood). 2017 Jul 1;36(7):1211-1217
pubmed: 28679807
Health Serv Res. 2021 Dec;56 Suppl 3:1370-1382
pubmed: 34490633
J Epidemiol Community Health. 2016 Jan;70(1):17-24
pubmed: 26202254
Health Econ. 2008 Jan;17(1 Suppl):S1-8
pubmed: 18186039
Am J Med. 1997 Aug 18;103(2A):12S-17S; discussion 17S-19S
pubmed: 9302893
Health Econ. 1999 Sep;8(6):485-96
pubmed: 10544314
Health Serv Res. 2021 Dec;56 Suppl 3:1335-1346
pubmed: 34390254
Med Care. 2009 Jul;47(7 Suppl 1):S51-5
pubmed: 19536019
Palliat Med. 2018 Dec;32(10):1584-1595
pubmed: 30273519
J Palliat Med. 2016 Jul;19(7):728-33
pubmed: 27159269
Age Ageing. 2004 Nov;33(6):556-61
pubmed: 15308460
Cancer. 2015 Aug 15;121(16):2814-20
pubmed: 25975179
J Palliat Med. 2005;8 Suppl 1:S161-73
pubmed: 16499464
Br J Cancer. 2015 Nov 3;113(9):1397-404
pubmed: 26325102
Ann Oncol. 2012 Aug;23(8):2006-2015
pubmed: 22345118
Womens Health Issues. 2008 May-Jun;18(3):199-209
pubmed: 18457755
Int J Public Health. 2013 Apr;58(2):257-67
pubmed: 22892713
J Pain Symptom Manage. 2016 Oct;52(4):588-599
pubmed: 27401511
Lancet. 2014 Jul 5;384(9937):83-92
pubmed: 24993914
Health Econ. 2004 Apr;13(4):315-27
pubmed: 15067670
JAMA. 2016 Jan 19;315(3):272-83
pubmed: 26784775
JAMA. 2012 Jan 4;307(1):39-40
pubmed: 22215161
J Pain Symptom Manage. 2009 Jul;38(1):75-80
pubmed: 19615630
J Palliat Med. 2012 May;15(5):548-54
pubmed: 22468739
BMJ Support Palliat Care. 2018 Jun;8(2):145-154
pubmed: 29305499
BMJ. 2002 Jun 1;324(7349):1291-2
pubmed: 12039810
BMC Palliat Care. 2016 Jul 25;15:64
pubmed: 27456495
Stroke. 2013 Nov;44(11):3229-31
pubmed: 23982712
Health Serv Res. 2021 Dec;56 Suppl 3:1347-1357
pubmed: 34378796
Med Care. 2017 Jul;55(7):698-705
pubmed: 28498196
Soc Sci Med. 2014 Nov;120:110-7
pubmed: 25238558

Auteurs

Carl Rudolf Blankart (CR)

KPM Center for Public Management, University of Bern, Bern, Switzerland.
Swiss Institute of Translational and Entrepreneurial Medicine, Bern, Switzerland.
Hamburg Center for Health Economics, Universität Hamburg, Hamburg, Germany.

Kees van Gool (K)

Centre for Health Economics Research and Evaluation (CHERE), University of Technology, Sydney, Australia.

Irene Papanicolas (I)

Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Department of Health Policy, London School of Economics, London, UK.

Enrique Bernal-Delgado (E)

Institute for Health Sciences in Aragon (IACS), Zaragoza, Aragon, Spain.

Nicholas Bowden (N)

Department of Women's and Children's Health, University of Otago, Dunedin, New Zealand.

Francisco Estupiñán-Romero (F)

Institute for Health Sciences in Aragon (IACS), Zaragoza, Aragon, Spain.

Robin Gauld (R)

Otago Business School and Centre for Health Systems and Technology, University of Otago, Dunedin, New Zealand.

Hannah Knight (H)

The Health Foundation, London, UK.

Olukorede Abiona (O)

Centre for Health Economics Research and Evaluation (CHERE), University of Technology, Sydney, Australia.

Kristen Riley (K)

Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Andrew J Schoenfeld (AJ)

Division of Orthopedic Surgery, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Kosta Shatrov (K)

KPM Center for Public Management, University of Bern, Bern, Switzerland.
Swiss Institute of Translational and Entrepreneurial Medicine, Bern, Switzerland.

Walter P Wodchis (WP)

Institute of Health Policy Management & Evaluation, University of Toronto, Toronto, Ontario, Canada.
Institute for Better Health, Trillium Health Partners, Mississauga, Ontario, Canada.

Jose F Figueroa (JF)

Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH